311 related articles for article (PubMed ID: 23153862)
1. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
[TBL] [Abstract][Full Text] [Related]
2. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.
Spratlin JL; Hui D; Hanson J; Butts C; Au HJ
Clin Colorectal Cancer; 2008 Mar; 7(2):118-25. PubMed ID: 18501071
[TBL] [Abstract][Full Text] [Related]
3. [Patient compliance and efficacy of diagnostic procedures in the surveillance of colorectal cancer: experience from a cancer center].
Riedl S; Lux T; Abel U; Theuer D
Z Gastroenterol; 2005 Apr; 43(4):357-65. PubMed ID: 15830301
[TBL] [Abstract][Full Text] [Related]
4. Identification of patients with high-risk for pulmonary metastases after curative resection of colorectal cancer.
Anannamcharoen S; Boonya-Ussadol C
J Med Assoc Thai; 2012 May; 95 Suppl 5():S86-91. PubMed ID: 22934451
[TBL] [Abstract][Full Text] [Related]
5. Surveillance approaches among colorectal cancer survivors after curative-intent.
Haggstrom DA; Imperiale TF
Minerva Gastroenterol Dietol; 2009 Dec; 55(4):483-500. PubMed ID: 19942831
[TBL] [Abstract][Full Text] [Related]
6. Receipt of guideline-recommended follow-up in older colorectal cancer survivors : a population-based analysis.
Cooper GS; Kou TD; Reynolds HL
Cancer; 2008 Oct; 113(8):2029-37. PubMed ID: 18780338
[TBL] [Abstract][Full Text] [Related]
7. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
8. Intensive radiographic and biomarker surveillance in stage II and III colorectal cancer.
Fora A; Patta A; Attwood K; Wilding G; Fakih M
Oncology; 2012; 82(1):41-7. PubMed ID: 22286543
[TBL] [Abstract][Full Text] [Related]
9. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
[TBL] [Abstract][Full Text] [Related]
10. First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs.
Kawamura YJ; Tokumitsu A; Mizokami K; Sasaki J; Tsujinaka S; Konishi F
Clin Colorectal Cancer; 2010 Jan; 9(1):48-51. PubMed ID: 20100688
[TBL] [Abstract][Full Text] [Related]
11. Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancer.
Cheung WY; Pond GR; Rother M; Krzyzanowska MK; Swallow C; Brierley J; Kaizer L; Myers J; Hajra L; Siu LL
Clin Colorectal Cancer; 2008 May; 7(3):191-6. PubMed ID: 18621637
[TBL] [Abstract][Full Text] [Related]
12. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.
Rodríguez-Moranta F; Saló J; Arcusa A; Boadas J; Piñol V; Bessa X; Batiste-Alentorn E; Lacy AM; Delgado S; Maurel J; Piqué JM; Castells A
J Clin Oncol; 2006 Jan; 24(3):386-93. PubMed ID: 16365182
[TBL] [Abstract][Full Text] [Related]
13. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
Yamamoto S; Akasu T; Fujita S; Moriya Y
Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
[TBL] [Abstract][Full Text] [Related]
14. Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer.
Steele SR; Chang GJ; Hendren S; Weiser M; Irani J; Buie WD; Rafferty JF;
Dis Colon Rectum; 2015 Aug; 58(8):713-25. PubMed ID: 26163950
[TBL] [Abstract][Full Text] [Related]
15. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
[TBL] [Abstract][Full Text] [Related]
16. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
17. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important.
Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP
Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital.
Techawathanawanna S; Nimmannit A; Akewanlop C
J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S189-98. PubMed ID: 22574549
[TBL] [Abstract][Full Text] [Related]
19. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.
Titu LV; Nicholson AA; Hartley JE; Breen DJ; Monson JR
Ann Surg; 2006 Mar; 243(3):348-52. PubMed ID: 16495699
[TBL] [Abstract][Full Text] [Related]
20. Strategies of follow-up for colorectal cancer: a survey of the American Society of Colon and Rectal Surgeons.
Giordano P; Efron J; Vernava AM; Weiss EG; Nogueras JJ; Wexner SD
Tech Coloproctol; 2006 Oct; 10(3):199-207. PubMed ID: 16969616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
